Year 2011,
, - , 01.04.2011
Abstract
Radyofrekans ablasyon uygulama kolaylığı, güvenilirliği ve başarılı sonuçları nedeni ile primer karaciğer tümörlerinin tedavisinde kullanılmaktadır. Radyofrekans ablasyon karaciğer transplantasyonu öncesi köprü tedavisi olarak da kullanılmaktadır. Burada radyofrekans ablasyonun nadir görülen iki komplikasyonunu bildiriyoruz.
Keywords
References
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Inci- dence, Mortality and Prevalence Worldwide. Lyon 2004; IARC Cancer- Base No. 5. version 2,0. Lyon: IARC Press.
- Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol in- jection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54:1151-6.
- Germani G, Pleguezuelo M, Gurusamy K, et al. Clinical outcomes of ra- diofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis. J Hepatol 2010; 52: 380-8.
- Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous complications encountered in a multicenter study. Radiology 2003; 226:441-51.
- Izumi N. Recent advances of radiofrequency ablation for early hepatocel- lular carcinoma. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 115-22.
- Rhim H, Yoon KH, Lee JM et al. Major complications after radio-frequ- ency thermal ablation of hepatic tumors: a spectrum of imaging fin- dings. Radiographics 2003; 23: 123-34.
- Geyik S, Akhan O, Abbasoğlu O, et al. Radiofrequency ablation of un- resectable hepatic tumors. Diagn Interv Radiol 2006; 12: 195-200.
Year 2011,
, - , 01.04.2011
Abstract
Radiofrequency ablation has become widely accepted as an approach against primary liver tumors because of its ease, safety of use and high level of effectiveness. radiofrequency ablation has also been performed as bridge therapy for hepatocellular carcinoma prior to liver transplantation. Herein, we report two rare complications of radiofrequency ablation.
References
- Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Inci- dence, Mortality and Prevalence Worldwide. Lyon 2004; IARC Cancer- Base No. 5. version 2,0. Lyon: IARC Press.
- Lin SM, Lin CJ, Lin CC, et al. Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol in- jection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less. Gut 2005; 54:1151-6.
- Germani G, Pleguezuelo M, Gurusamy K, et al. Clinical outcomes of ra- diofrequency ablation, percutaneous alcohol and acetic acid injection for hepatocellular carcinoma: a meta-analysis. J Hepatol 2010; 52: 380-8.
- Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous complications encountered in a multicenter study. Radiology 2003; 226:441-51.
- Izumi N. Recent advances of radiofrequency ablation for early hepatocel- lular carcinoma. J Gastroenterol Hepatol 2011; 26 (Suppl 1): 115-22.
- Rhim H, Yoon KH, Lee JM et al. Major complications after radio-frequ- ency thermal ablation of hepatic tumors: a spectrum of imaging fin- dings. Radiographics 2003; 23: 123-34.
- Geyik S, Akhan O, Abbasoğlu O, et al. Radiofrequency ablation of un- resectable hepatic tumors. Diagn Interv Radiol 2006; 12: 195-200.
There are 7 citations in total.
Details
| Primary Language | Turkish |
|---|---|
| Journal Section | Articles |
| Authors | |
| Publication Date | April 1, 2011 |
| Published in Issue | Year 2011 |